A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects

Evaluate the effect of two hand antiseptic products on hand skin conditions of healthy volunteers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

25 year–55 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Female age 25 - 55
Subject agrees not to use any hand wash products on their hands other than what has been provided in the study.
Subject agrees not to use any moisturizers or any skin products on their hands during the study
Subject agrees to use gloves to protect hands from activities such as dish washing
Subject is willing to sign the Informed Consent and HIPAA
Subject agrees to comply with the study requirement

Exclusion criteria

Subject has a history of psoriasis, active dermatitis, skin reactions, cracked, irritated, broken skin, skin infection on their hands
Subject has scaly skin on hands based on Visual Scoring Scale at Day 1
Subject has a sensitivity or history of skin reactions to any study materials (eg, alcohol, chlorhexidine gluconate or zinc pyrithone or latex in the gloves)
Subject has been using moisturizing products or any products on their arms and hands within 5 days prior to participation in the study
Subject is pregnant
Study coordinator believes the subject is unsuitable for inclusion in the study

Treatment and study plan

Avagard

Drug

Topical solution, 6 mL, 6 applications/day for 14 days.

Purell Surgical Scrub

Drug

Topical solution, 4 mL, 6 applications/day for 14 days.

Other names: Purell Surgical Scrub with Moisturizers

Primary outcomes

Change From Baseline in Skin Health, Visual Skin Score (VSS) at 14 Days

Time frame: Baseline and 14 days

Observe VSS score at 14 days, and graded change of skin health from baseline using scale of 0 (normal) - 5 (very scaly).

Sponsors and collaborators

Lead sponsor

Solventum US LLC

Industry

Collaborators

Registry information

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2008
First posted: Aug 8, 2008
Registry last updated: Dec 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed